UNICANCER
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.unicancer.fr
Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer
- First Posted Date
- 2016-05-16
- Last Posted Date
- 2023-09-01
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 203
- Registration Number
- NCT02773004
Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 18
- Registration Number
- NCT02754011
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
🇫🇷Institut de Cancérologie de l'Ouest, Saint-herblain, France
EXPRESS: EXcePtional RESponSe - Exceptional and Unexpected Response to Targeted Therapies
- First Posted Date
- 2016-03-08
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 182
- Registration Number
- NCT02701907
- Locations
- 🇫🇷
CHU d'Angers, Angers, France
🇫🇷Institut de Cancérologie de l'Ouest (site Paul Papin), Angers, France
🇫🇷CHU d'Auxerre, Auxerre, France
Neoadjuvant Treatment for Advanced Rectal Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2015-09-16
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 103
- Registration Number
- NCT02551237
- Locations
- 🇫🇷
Hôpital Avicenne, Bobigny, France
🇫🇷Institut Bergonié, Bordeaux, France
🇫🇷CHU Henri Mondor, Créteil, France
A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2015-09-03
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 171
- Registration Number
- NCT02539537
- Locations
- 🇫🇷
Hôpital Trousseau, Chambray-les-tours, France
🇫🇷Hôpital Avicenne, Bobigny, France
🇫🇷CHU Amiens - Hôpital Nord, Amiens, France
A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature
- First Posted Date
- 2015-07-22
- Last Posted Date
- 2021-06-08
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 41
- Registration Number
- NCT02505048
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
🇫🇷Institut Paoli Calmettes, Marseille, France
Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor
- First Posted Date
- 2015-05-14
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 150
- Registration Number
- NCT02444390
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
🇫🇷Institut Claudius Regaud, Toulouse, France
🇫🇷Clinique Armoricaine de Radiologie, Saint-Brieuc, France
Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC)
- Conditions
- Interventions
- First Posted Date
- 2015-04-01
- Last Posted Date
- 2022-03-24
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 139
- Registration Number
- NCT02404935
- Locations
- 🇫🇷
Centre Hospitalier d'Auxerre, Auxerre, France
🇫🇷Centre Hospitalier Intercommunal Cote Basque, Bayonne, France
🇫🇷Centre Hospitalier de Beauvais, Beauvais, France
Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women
- Conditions
- Interventions
- First Posted Date
- 2015-03-27
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 125
- Registration Number
- NCT02400567
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, France
🇫🇷Institut Curie, Paris, France
Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2019-10-29
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 72
- Registration Number
- NCT02393820
- Locations
- 🇫🇷
Centre Jean Perrin, Clermont-Ferrand, France
🇫🇷CHU Bordeaux, Bordeaux, France
🇫🇷Gustave Roussy, Villejuif, France